Relapse of severe neurosarcoidosis with switch from originator infliximab to biosimilar.
Saved in:
| Title: | Relapse of severe neurosarcoidosis with switch from originator infliximab to biosimilar. |
|---|---|
| Authors: | Kidd DP; From the Centre for Neurosarcoidosis, Neuroimmunology Unit, Institute of Immunity and Transplantation, University College London, United Kingdom. d.kidd@ucl.ac.uk., Galloway M; From the Centre for Neurosarcoidosis, Neuroimmunology Unit, Institute of Immunity and Transplantation, University College London, United Kingdom., Wilhelm T; From the Centre for Neurosarcoidosis, Neuroimmunology Unit, Institute of Immunity and Transplantation, University College London, United Kingdom. |
| Source: | Neurology [Neurology] 2020 Jun 02; Vol. 94 (22), pp. 991-993. Date of Electronic Publication: 2020 May 11. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1526-632X |
|---|---|
| DOI: | 10.1212/WNL.0000000000009526 |
